Cargando…

Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency

Lysine (K) type cationic lipid with a propyl spacer and ditetradecyl hydrophobic moieties composing liposomes, K3C14, previously studied for gene delivery, were reported to activate the NLRP3 inflammasomes in human macrophages via the conventional phagolysosomal pathway. In this study, K3C16, a prop...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Jieyan, Li, Tianshu, Próchnicki, Tomasz, Horvath, Gabor, Latz, Eicke, Takeoka, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462779/
https://www.ncbi.nlm.nih.gov/pubmed/31011633
http://dx.doi.org/10.1016/j.bbrep.2019.100623
_version_ 1783410638497775616
author He, Jieyan
Li, Tianshu
Próchnicki, Tomasz
Horvath, Gabor
Latz, Eicke
Takeoka, Shinji
author_facet He, Jieyan
Li, Tianshu
Próchnicki, Tomasz
Horvath, Gabor
Latz, Eicke
Takeoka, Shinji
author_sort He, Jieyan
collection PubMed
description Lysine (K) type cationic lipid with a propyl spacer and ditetradecyl hydrophobic moieties composing liposomes, K3C14, previously studied for gene delivery, were reported to activate the NLRP3 inflammasomes in human macrophages via the conventional phagolysosomal pathway. In this study, K3C16, a propyl spacer bearing lysine type lipids with dihexadecyl moieties (an extension of two hydrocarbon tail length) were compared with K3C14 as liposomes. Such a small change in tail length did not alter the physical properties such as size distribution, zeta potential and polydispersity index (PDI). The NLRP3 activation potency of K3C16 was shown to be 1.5-fold higher. Yet, the toxicity was minimal, whereas K3C14 has shown to cause significant cell death after 24 h incubation. Even in the presence of endocytosis inhibitors, cytochalasin D or dynasore, K3C16 continued to activate the NLRP3 inflammasomes and to induce IL-1β release. To our surprise, K3C16 liposomes were confirmed to fuse with the plasma membrane of human macrophages and CHO-K1 cells. It is demonstrated that the change in hydrophobic tail length by two hydrocarbons drastically changed a cellular entry route and potency in activating the NLRP3 inflammasomes.
format Online
Article
Text
id pubmed-6462779
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-64627792019-04-22 Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency He, Jieyan Li, Tianshu Próchnicki, Tomasz Horvath, Gabor Latz, Eicke Takeoka, Shinji Biochem Biophys Rep Research Article Lysine (K) type cationic lipid with a propyl spacer and ditetradecyl hydrophobic moieties composing liposomes, K3C14, previously studied for gene delivery, were reported to activate the NLRP3 inflammasomes in human macrophages via the conventional phagolysosomal pathway. In this study, K3C16, a propyl spacer bearing lysine type lipids with dihexadecyl moieties (an extension of two hydrocarbon tail length) were compared with K3C14 as liposomes. Such a small change in tail length did not alter the physical properties such as size distribution, zeta potential and polydispersity index (PDI). The NLRP3 activation potency of K3C16 was shown to be 1.5-fold higher. Yet, the toxicity was minimal, whereas K3C14 has shown to cause significant cell death after 24 h incubation. Even in the presence of endocytosis inhibitors, cytochalasin D or dynasore, K3C16 continued to activate the NLRP3 inflammasomes and to induce IL-1β release. To our surprise, K3C16 liposomes were confirmed to fuse with the plasma membrane of human macrophages and CHO-K1 cells. It is demonstrated that the change in hydrophobic tail length by two hydrocarbons drastically changed a cellular entry route and potency in activating the NLRP3 inflammasomes. Elsevier 2019-04-12 /pmc/articles/PMC6462779/ /pubmed/31011633 http://dx.doi.org/10.1016/j.bbrep.2019.100623 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
He, Jieyan
Li, Tianshu
Próchnicki, Tomasz
Horvath, Gabor
Latz, Eicke
Takeoka, Shinji
Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency
title Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency
title_full Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency
title_fullStr Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency
title_full_unstemmed Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency
title_short Membrane fusogenic lysine type lipid assemblies possess enhanced NLRP3 inflammasome activation potency
title_sort membrane fusogenic lysine type lipid assemblies possess enhanced nlrp3 inflammasome activation potency
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462779/
https://www.ncbi.nlm.nih.gov/pubmed/31011633
http://dx.doi.org/10.1016/j.bbrep.2019.100623
work_keys_str_mv AT hejieyan membranefusogeniclysinetypelipidassembliespossessenhancednlrp3inflammasomeactivationpotency
AT litianshu membranefusogeniclysinetypelipidassembliespossessenhancednlrp3inflammasomeactivationpotency
AT prochnickitomasz membranefusogeniclysinetypelipidassembliespossessenhancednlrp3inflammasomeactivationpotency
AT horvathgabor membranefusogeniclysinetypelipidassembliespossessenhancednlrp3inflammasomeactivationpotency
AT latzeicke membranefusogeniclysinetypelipidassembliespossessenhancednlrp3inflammasomeactivationpotency
AT takeokashinji membranefusogeniclysinetypelipidassembliespossessenhancednlrp3inflammasomeactivationpotency